BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36073904)

  • 1. Key Residues in δ Opioid Receptor Allostery Explored by the Elastic Network Model and the Complex Network Model Combined with the Perturbation Method.
    Chen L; Gong W; Han Z; Zhou W; Yang S; Li C
    J Chem Inf Model; 2022 Dec; 62(24):6727-6738. PubMed ID: 36073904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propagation of the Allosteric Modulation Induced by Sodium in the δ-Opioid Receptor.
    Sun X; Laroche G; Wang X; Ågren H; Bowman GR; Giguère PM; Tu Y
    Chemistry; 2017 Apr; 23(19):4615-4624. PubMed ID: 28182309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the allosteric mechanism of GPCR A
    Wang Q; Zhang S; Han Z; Fan H; Li C
    J Biomol Struct Dyn; 2021 Oct; 39(17):6431-6439. PubMed ID: 32741308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions.
    Shang Y; LeRouzic V; Schneider S; Bisignano P; Pasternak GW; Filizola M
    Biochemistry; 2014 Aug; 53(31):5140-9. PubMed ID: 25073009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors.
    Shang Y; Yeatman HR; Provasi D; Alt A; Christopoulos A; Canals M; Filizola M
    ACS Chem Biol; 2016 May; 11(5):1220-9. PubMed ID: 26841170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular control of δ-opioid receptor signalling.
    Fenalti G; Giguere PM; Katritch V; Huang XP; Thompson AA; Cherezov V; Roth BL; Stevens RC
    Nature; 2014 Feb; 506(7487):191-6. PubMed ID: 24413399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on allosteric communication in U1A-snRNA binding interactions: network analysis combined with molecular dynamics data.
    Shao Q; Gong W; Li C
    Biophys Chem; 2020 Sep; 264():106393. PubMed ID: 32653695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Selective Novel Hits against
    Nyamai DW; Tastan Bishop Ö
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric effects of sodium ion binding on activation of the m3 muscarinic g-protein-coupled receptor.
    Miao Y; Caliman AD; McCammon JA
    Biophys J; 2015 Apr; 108(7):1796-1806. PubMed ID: 25863070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer.
    Parenty G; Appelbe S; Milligan G
    Biochem J; 2008 Jun; 412(2):245-56. PubMed ID: 18307412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors.
    Livingston KE; Stanczyk MA; Burford NT; Alt A; Canals M; Traynor JR
    Mol Pharmacol; 2018 Feb; 93(2):157-167. PubMed ID: 29233847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rigid Residue Scan Simulations Systematically Reveal Residue Entropic Roles in Protein Allostery.
    Kalescky R; Zhou H; Liu J; Tao P
    PLoS Comput Biol; 2016 Apr; 12(4):e1004893. PubMed ID: 27115535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsets of Slow Dynamic Modes Reveal Global Information Sources as Allosteric Sites.
    Altintel B; Acar B; Erman B; Haliloglu T
    J Mol Biol; 2022 Sep; 434(17):167644. PubMed ID: 35644497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.
    Filizola M; Laakkonen L; Loew GH
    Protein Eng; 1999 Nov; 12(11):927-42. PubMed ID: 10585498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protonation-Induced Dynamic Allostery in PDZ Domain: Evidence of Perturbation-Independent Universal Response Network.
    Kumawat A; Chakrabarty S
    J Phys Chem Lett; 2020 Nov; 11(21):9026-9031. PubMed ID: 33043672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allostery at opioid receptors: modulation with small molecule ligands.
    Livingston KE; Traynor JR
    Br J Pharmacol; 2018 Jul; 175(14):2846-2856. PubMed ID: 28419415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.
    Livingston KE; Traynor JR
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18369-74. PubMed ID: 25489080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.
    Hui WQ; Cheng Q; Liu TY; Ouyang Q
    J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in allosteric network affects binding affinities of PDZ domains: analysis through perturbation response scanning.
    Gerek ZN; Ozkan SB
    PLoS Comput Biol; 2011 Oct; 7(10):e1002154. PubMed ID: 21998559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3D model of the delta opioid receptor and ligand-receptor complexes.
    Alkorta I; Loew GH
    Protein Eng; 1996 Jul; 9(7):573-83. PubMed ID: 8844829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.